1.Metabolism-related diseases are accompanied by inflammation. MA Xiao-Feng and his coworkers summarize literatures concerning the role of fatty acid synthase (FAS) as a therapeutic target in obesity and related inflammation as well as providing evidence to support the anti-inflammation potential of TCMs with FAS inhibitory activities (Page 目录，. WU Li-Li and her collaborators summarize inflammatory molecules and pathways in relation to renal injury of diabetic nephropathy (DN), and discuss potential traditional Chinese medicine (TCM) strategies to treat DN via targeting inflammatory factors (Page 目录;2.Metabolism-related diseases are accompanied by inflammation. MA Xiao-Feng and his coworkers summarize literatures concerning the role of fatty acid synthase (FAS) as a therapeutic target in obesity and related inflammation as well as providing evidence to support the anti-inflammation potential of TCMs with FAS inhibitory activities (Page 目录，. XU Yong and his group clarify how gut microbiota induces systemic low-grade inflammation and development of metabolic diseases. They also explore the intervention of berberine on metabolic diseases via affecting the intestinal microbiota-inflammation axis (Page 目录

Tel: 13552534019, E-mail:herq@ibp.ac.cn